Loss of smell, or anosmia, has emerged as one of the hallmark symptoms of COVID-19, distinguishing it from other respiratory illnesses. This sudden loss of smell can be disconcerting and impactful on daily life. Understanding...
From Dr. Joseph Mercola Since COVID-19 first entered the scene, exchange of ideas has basically been outlawed. By sharing my views and those from various experts throughout the pandemic on COVID treatments and the experimental...
Genetic analysis using the Oak Ridge National Lab supercomputer called the Summit has revealed an interesting new hypothesis that helps explain the disease progression of COVID-19. A September 1, 2020, Medium article1 by Thomas Smith...
Advertisement Continue reading the main story Supported by Continue reading the main story A Pill to Treat Covid-19? The U.S. Is Betting on It. A new $ 3.2 billion program will support the development of...
In the three months since Johnson & Johnson’s COVID-19 vaccine received emergency use authorization from the U.S. Food and Drug Administration, more than 10 million Americans have received the vaccine, according to the Centers for...
CureVac’s late-stage COVID-19 vaccine trial flop clearly showed that not all pandemic shots are alike. But where does that leave the German biotech and its Big Pharma partners? For one, ongoing collaborations with Bayer and GlaxoSmithKline aren’t going...